The Advanced Medical Technology Transfer Center (AMTTC), situated in BOAO Lecheng within the Hainan Free Trade Port, represents a pivotal collaboration between Hainan Free Trade Port Boao Hope City (Hope City) and the China Clinical Translational Medicine Industry Society (CCTMIS). AMTTC’s core mission is to accelerate the adoption of state-of-the-art medical products and technologies, ultimately enriching the landscape of healthcare and well-being in China.
At AMTTC, we are steadfast in our commitment to introducing cutting-edge international medical innovations to China, thereby contributing significantly to the advancement of healthcare and overall well-being in the region.
CCTMIS, a constituent of the National Association of Health Industry and Enterprise Management (NAHIEM), serves as a robust network that spans across China. Within this expansive network, CCTMIS seamlessly integrates clinical institutes, funding sources, enterprises, and research organizations. CCTMIS’s primary aim is to cultivate a thriving translational medical ecosystem that facilitates rapid progress in medical translation.
Over 10,000 academicians, clinical institutions and experts
over 3,000 medical production and service enterprises
over 300 medical industry investment and financing institutions
over 200 scientific R&D and research institutions
A thriving community
As of today, CCTMIS boasts a dynamic consortium comprising more than 60 medical working groups, each bolstered by a dedicated team of clinicians from diverse regions across China. These groups encompass a wide spectrum of medical specialties, including but not limited to Cerebrovascular disease and Alzheimer’s disease, Vascular diagnosis and treatment, Endocrine and metabolic disease, Pain rehabilitation, Allergic reaction, Osteopathic Medicine, and others. It’s important to note that CCTMIS operates as an inclusive and open platform, continuously fostering growth and expansion.
Boao Hope City, also known as the Hainan Boao Lecheng International Medical Tourism Pilot Zone (the “Pilot Zone”) was established with the approval of the State Council on February 28, 2013 and granted certain preferential policies.
Local quick landing by franchise use of innovative medical products
NMPA fast-track approval for cutting-edge international medical products
Real-world data collected from medical franchise use facilitates NMPA registration
Visa Free For 59 countries
Low tax rate
Medical Franchise Usage can validate the product’s compatibility with local healthcare practices, patient preferences, and regulatory standards. With Chinese Mainland Market Adaption Assessment, your company can tailor your marketing and product strategies to maximize acceptance and success in the Chinese market.
Real-world data generated in Hope City can expedite the NMPA registration process and reduce clinical study expenses in China. AMTTC can streamline your NMPA registration pathway, leading to cost savings and faster registration timelines.